- Home
- CF vs RPRX Comparison
CF vs RPRX Comparison
Compare CF & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CF
- RPRX
- Stock Information
- Founded
- CF 1946
- RPRX 1996
- Country
- CF United States
- RPRX United States
- Employees
- CF N/A
- RPRX N/A
- Industry
- CF Agricultural Chemicals
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CF Industrials
- RPRX Health Care
- Exchange
- CF Nasdaq
- RPRX Nasdaq
- Market Cap
- CF 14.0B
- RPRX 16.2B
- IPO Year
- CF 2005
- RPRX 2020
- Fundamental
- Price
- CF $78.46
- RPRX $39.71
- Analyst Decision
- CF Hold
- RPRX Strong Buy
- Analyst Count
- CF 14
- RPRX 3
- Target Price
- CF $92.92
- RPRX $46.00
- AVG Volume (30 Days)
- CF 2.6M
- RPRX 4.5M
- Earning Date
- CF 11-05-2025
- RPRX 11-05-2025
- Dividend Yield
- CF 2.55%
- RPRX 2.21%
- EPS Growth
- CF 31.44
- RPRX N/A
- EPS
- CF 8.27
- RPRX 1.75
- Revenue
- CF $6,736,000,000.00
- RPRX $2,349,844,000.00
- Revenue This Year
- CF $19.63
- RPRX $36.16
- Revenue Next Year
- CF N/A
- RPRX $2.04
- P/E Ratio
- CF $9.48
- RPRX $22.74
- Revenue Growth
- CF 12.59
- RPRX 3.70
- 52 Week Low
- CF $67.34
- RPRX $24.05
- 52 Week High
- CF $104.45
- RPRX $41.24
- Technical
- Relative Strength Index (RSI)
- CF 37.04
- RPRX 59.32
- Support Level
- CF $76.48
- RPRX $37.31
- Resistance Level
- CF $79.15
- RPRX $40.00
- Average True Range (ATR)
- CF 2.00
- RPRX 1.03
- MACD
- CF -0.40
- RPRX -0.03
- Stochastic Oscillator
- CF 21.78
- RPRX 85.66
About CF CF Industries Holdings Inc.
CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.